Construction of MicroRNA-mRNA Regulatory Network in the Molecular Mechanisms of Bleomycin-Induced Pulmonary Fibrosis.

Autor: Chen, Liuyin¹ (AUTHOR), Shi, Zhiling¹ (AUTHOR), Deng, Lin² (AUTHOR), Wu, Jiangtao¹ (AUTHOR), Wang, Housheng¹ (AUTHOR), Lu, Yushuang¹ (AUTHOR), Fan, Ting¹ (AUTHOR), Lu, Jiamei¹ (AUTHOR), Huang, Weimei¹ (AUTHOR), Hu, Kai¹ (AUTHOR)

Publikováno v: BioMed Research International. 3/30/2022, p1-12. 12p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Predicting Nomogram for Severe Oral Mucositis in Patients with Nasopharyngeal Carcinoma during Intensity-Modulated Radiation Therapy: A Retrospective Cohort Study.

Autor: Liu Z; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.; Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning 530021, China.; Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Nanning 530021, China., Huang L; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.; Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning 530021, China.; Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Nanning 530021, China., Wang H; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.; Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning 530021, China.; Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Nanning 530021, China., Shi Z; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.; Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning 530021, China.; Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Nanning 530021, China., Huang Y; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.; Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning 530021, China.; Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Nanning 530021, China., Liang L; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.; Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning 530021, China.; Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Nanning 530021, China., Wang R; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.; Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning 530021, China.; Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Nanning 530021, China., Hu K; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.; Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning 530021, China.; Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Nanning 530021, China.

Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Dec 23; Vol. 30 (1), pp. 219-232. Date of Electronic Publication: 2022 Dec 23.